CD14 and amyotrophic lateral sclerosis: With regard to PB changes, CD14+CD16+ monocyte levels were increased in ALS patients compared with dementia (7.94%, IQR 4.14–10.87, P = 0.007) patients, but not in PPMS patients (8.42%, IQR 5.92–12.97, P = 0.113).